Metabolic syndrome treatment: focusing on acarbose

Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients with impaired glucose tolerance (IGT) and AH.Mat...

Full description

Bibliographic Details
Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	I. E. Chazova, B. B. Mychka
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-04-01
Subjects:	arterial hypertension metabolic syndrome insulin resistance acarbose
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1331

Similar Items

Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome
by: S. V. Nedogoda, et al.
Published: (2006-04-01)

Combined antihypertensive therapy in treating patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-06-01)

Evaluating the Effects of Acarbose on Anthropometry Indexes and Metabolic Markers in Patients with Metabolic Syndrome in Comparison to Placebo, in Isfahan City, Iran
by: Noushin Khalili, et al.
Published: (2018-08-01)

HYPERURICEMIA CORRECTION IN MEN WITH METABOLIC SYNDROME: ACARBOSE POTENTIAL
by: M. V. Reshetnyak, et al.
Published: (2011-04-01)

Perindopril metabolic effects and organo-protective action in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2007-04-01)

Clinical implications of dual therapy of acarbose plus myo-inositol on the thyroid profile in women with polycystic ovary syndrome
by: Marina Andavar, et al.
Published: (2024-11-01)

Evaluation of the effects of acarbose on weight and metabolic, inflammatory, and cardiovascular markers in patients with obesity and overweight
by: Noushin Khalili, et al.
Published: (2020-01-01)

Combined therapy in metabolic syndrome treatment
by: Yu. V. Zhernakova, et al.
Published: (2010-08-01)

Cerebrovascular events primary prevention in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2006-04-01)

Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
by: P. Rosenbaum, et al.
Published: (2002-08-01)

Obesity pharmaceutical correction in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2005-08-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01)

Diuretics in patients with metabolic disturbances
by: I. E. Chazova, et al.
Published: (2007-04-01)

Affection of target organs in hypertensive patients with and without metabolic syndrome
by: G Kh Sharipova, et al.
Published: (2009-06-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
by: J. A. Villarreal-Rodriguez, et al.
Published: (2020-08-01)

Beta-adrenoblockers in patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-04-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

Carotid intima-media thickness in arterial hypertension patients with and without metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2009-04-01)

Continuous Glucose Monitoring Systems and the Efficacy of Acarbose Treatment in Cystic Fibrosis-related Dysglycemia
by: Emrullah Arslan, et al.
Published: (2025-03-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
by: A S Ryazanov, et al.
Published: (2003-03-01)

MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM
by: V. B. Mychka, et al.
Published: (2014-03-01)

A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01)

Open, multi-center randomized research and clinical program MINOTAUROS: intermediate data analysis
by: I. E. Chazova, et al.
Published: (2006-04-01)

Effects of Acarbose Addition on Ruminal Bacterial Microbiota, Lipopolysaccharide Levels and Fermentation Characteristics
by: Yu-yang Yin, et al.
Published: (2014-12-01)

Fixed dose combination of perindopril with indapamide in primary prevention of cerebrovascular complications among patients with metabolic syndrome and arterial hypertension
by: V. B. Mychka, et al.
Published: (2006-02-01)

Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01)

Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
by: Aditya Maulana Perdana Putra, et al.
Published: (2021-05-01)

NMR Data Analysis of Acarbose
by: LI Yujiang, et al.
Published: (2025-06-01)

Heart pathology in patients with arterial hypertension and metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01)

Intima- media thickness of соmmоn carotid artery in patients with arterial hypertension and present or absent metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

INFLUENCE OF ACARBOSE ON POSTPRANDIAL DYSMETABOLISM: RESULTS OF AN OPEN-LABEL RANDOMIZED STUDY
by: A. Ya. Cherniak, et al.
Published: (2015-09-01)

Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
by: Hsin-Hua Chen, et al.
Published: (2020-04-01)

The efficacy and tolerability of intermittent prandial acarbose to reduce glucose spikes in healthy individuals
by: A. Isman, et al.
Published: (2023-01-01)

Investigating Taste Perception of Maltodextrins Using Lactisole and Acarbose
by: Claudia Hartley, et al.
Published: (2024-07-01)

The 4-α-Glucanotransferase AcbQ Is Involved in Acarbose Modification in <i>Actinoplanes</i> sp. SE50/110
by: Sophia Nölting, et al.
Published: (2023-03-01)

Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice
by: Natalya A. Borozdina, et al.
Published: (2024-06-01)

THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME
by: L. V. Kremneva, et al.
Published: (2015-09-01)

The Safety and Efficacy of Rosa Damascena Extract in Patients with Type II Diabetes: preliminary Report of a Triple Blind Randomized Acarbose Controlled Clinical Trial
by: Mojgan Sanjari, et al.
Published: (2019-01-01)